Companyprofilesandconferences.com glad to promote a new report on "Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products who provides key information about the company, its major products and brands.

1. Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis
Companyprofilesandconferences.com glad to promote a new report on "Myriad Genetics, Inc.
(MYGN) - Product Pipeline Analysis" which is a source for data, analysis, and actionable
intelligence on the company’s portfolio of pipeline products who provides key information about
the company, its major products and brands.
July, 23, 2014 : Company Profiles and Conferences presents a Company Report on "Teras
Resources Inc. (TRA) - Company Capsule", who covers ongoing clinical trials (wherever
applicable) with information on trial name, trial objective, sponsor, trial design , trial status and
phase, estimated start and end date.
Summary
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the
discovery and commercialization of molecular diagnostic tests that assesses person’s risk
towards disease development, disease progression and recurrence and guide through the
treatment decisions. Its product portfolio iincludes nine commercial molecular diagnostic tests,
namely, six predictive medicine tests; one prognostic medicine test; and two personalized
medicine tests in the areas of oncology and CNS related disorders. Its commercial molecular
diagnostic tests comprise BRACAnalysis, COLARIS, MELARIS, PANEXIA, COLARIS AP,
PREZEON, TheraGuide, TruCulture, DiscoveryMAP, Prolaris and RodentMap The company
along with its subsidiaries operates in the US, Spain, France, Switzerland, the UK, Canada, the
Netherlands and Italy. The company is headquartered in Salt Lake City, Utah, the US.
The company mainly focuses on three key initiatives, namely, to grow and expand its existing
products and markets, to develop its business internationally and have established operations in
Europe, and to introduce new transformative products across a diverse set of disease indications,
complementing its current businesses in oncology, women’s health and urology.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio
of pipeline products. The report provides key information about the company, its major products
and brands.
The report enhances decision making capabilities and help to create effective counter strategies
to gain competitive advantage.
Scope:
• The report reviews detailed company profile with information on business description,
key company facts, major products and services, key competitors, key employees,
locations and subsidiaries and recent developments

2. • The report analyzes all pipeline products in development for the company Myriad
Genetics, Inc.
• The report provides pipeline analysis on all pipeline products of the company (by
equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on
pipeline territory, stage of development, device class, regulatory path, indication(s),
application(s) and estimated launch date
• The report provides detailed description of products in development, technical
specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on
trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and
end date.
Reasons to Buy:
• Develop business strategies by understanding the trends and developments driving the
medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by
understanding the competitor portfolio
• To formulate effective R&D strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely
to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most
promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the
competitors’ pipeline products through review of the clinical trials, stage and of
development, etc
• Identify, understand and capitalize the next high-value products that your competitor
would add in its portfolio

3. For more information kindly visit:
http://www.companyprofilesandconferences.com/researchindex/Medical-Devices-c32/Myriad-
Genetics-Inc-MYGN-Product-Pipeline-Analysis.html
Related link: http://www.companyprofilesandconferences.com/researchindex/Medical-
Devices.asp
About Company Profiles and Conferences
Search thousands of company profiles, SWOT analysis reports and company financials. Search
by industry sector, or simply search all company profiles by company name.
companyprofilesandconferences.com contains one of the world's largest collections of company
insight and company profiles from leading global market report publishers and analysts. Global
brands rely on companyprofilesandconferences.com for their strategic company insight and
company profile needs.
Contact us at:
Company Profiles And Conferences
Mob +919223375060 / 919223767111
Fax : +91 22 27810778
E-mail : info@companyprofilesandconferences.com
Website : www.companyprofilesandconferences.com